{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:14:46Z","timestamp":1761844486211},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol Suppl"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11789-015-0068-y","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T13:02:12Z","timestamp":1422882132000},"page":"46-50","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study"],"prefix":"10.1007","volume":"10","author":[{"given":"Reinhard","family":"Klingel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Heibges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Fassbender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"68_CR1","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K et al (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31:2844\u20132853","journal-title":"Eur Heart J"},{"key":"68_CR2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1001\/jama.1993.03510180065035","volume":"270","author":"PM Ridker","year":"1993","unstructured":"Ridker PM, Hennekens CH, Stampfer MJ (1993) A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 270:2195\u20132199","journal-title":"JAMA"},{"key":"68_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/abio.2000.4904","volume":"288","author":"C Edelstein","year":"2001","unstructured":"Edelstein C, Hinman J, Marcovina S et al (2001) Properties of human free apolipoprotein(a) and lipoprotein(a) after either freezing or lyophilization in the presence and absence of cryopreservatives. Anal Biochem 288:201\u2013208","journal-title":"Anal Biochem"},{"key":"68_CR4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1373\/clinchem.2003.030031","volume":"50","author":"N Rifai","year":"2004","unstructured":"Rifai N, Ma J, Sacks FM et al (2004) Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the physicians\u2019 health study. Clin Chem 50:1364\u20131371","journal-title":"Clin Chem"},{"key":"68_CR5","unstructured":"German Federal Ministry of Health (2008) Publication of a decision of Federal Joint Committee on apheresis for isolated Lp(a)-elevation with progressive cardiovascular disease. Transactions Ger Fed Ministries (BAnz) 138:3321"},{"key":"68_CR6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ncpcardio1456","volume":"6","author":"BR Jaeger","year":"2009","unstructured":"Jaeger BR, Richter Y, Nagel D et al (2009) Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events. Nat Clin Pract Cardiovasc Med 6:229\u2013239","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"68_CR7","doi-asserted-by":"crossref","unstructured":"Leebmann J, R\u00f6seler E, Julius U et al, for the Pro(a)LiFe-study group (2013) Lipoprotein apheresis in patients with maximally tolerated lipid lowering therapy, Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease\u2014prospective observational multicenter study. Circulation 128:2567\u20132576","DOI":"10.1161\/CIRCULATIONAHA.113.002432"},{"key":"68_CR8","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/clinchem\/46.12.1956","volume":"46","author":"SM Marcovina","year":"2000","unstructured":"Marcovina SM, Albers JJ, Scanu AM et al (2000) Use of a reference material proposed by the international federation of clinical chemistry and laboratory medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem 46:1956\u20131967","journal-title":"Clin Chem"},{"key":"68_CR9","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2003.023689","volume":"49","author":"SM Marcovina","year":"2003","unstructured":"Marcovina SM, Koschinsky ML, Albers JJ et al (2003) Report of the national heart, lung, and blood institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions. Clin Chem 49:1785\u20131796","journal-title":"Clin Chem"},{"key":"68_CR10","first-page":"412","volume":"303","author":"Emerging Risk Factors Collaboration","year":"2009","unstructured":"Emerging Risk Factors Collaboration (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 303:412\u2013423","journal-title":"JAMA"},{"key":"68_CR11","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1194\/jlr.M008961","volume":"51","author":"SJ Nicholls","year":"2010","unstructured":"Nicholls SJ, Tang WHW, Scoffone H et al (2010) Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. J Lipid Res 51:3055\u20133061","journal-title":"J Lipid Res"},{"key":"68_CR12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","volume":"104","author":"AR Sharrett","year":"2001","unstructured":"Sharrett AR, Ballantyne CM, Coady SA et al (2001) Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study. Circulation 104:1108\u20131113","journal-title":"Circulation"},{"key":"68_CR13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1373\/clinchem.2006.079947","volume":"53","author":"GT Jones","year":"2007","unstructured":"Jones GT, van Rij AM, Cole J et al (2007) Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease. Clin Chem 53:679\u2013685","journal-title":"Clin Chem"},{"key":"68_CR14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/clinchem\/45.7.1039","volume":"45","author":"LJ Seman","year":"1999","unstructured":"Seman LJ, DeLuca C, Jenner JL et al (1999) Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham heart study. Clin Chem 45:1039\u20131046","journal-title":"Clin Chem"},{"key":"68_CR15","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2009.10.080","volume":"55","author":"S Erqou","year":"2010","unstructured":"Erqou S, Thompson A, Di Angelantonio E et al (2010) Apolipoprotein(a) isoforms and the risk of vascular disease. J Am Coll Cardiol 55:2160\u20132167","journal-title":"J Am Coll Cardiol"},{"key":"68_CR16","doi-asserted-by":"crossref","first-page":"13492","DOI":"10.1021\/bi00249a038","volume":"33","author":"GM Fless","year":"1994","unstructured":"Fless GM, Snyder ML, Furbee JW et al (1994) Subunit composition of lipoprotein(a) protein. Biochemistry 33:13492\u201313501","journal-title":"Biochemistry"},{"key":"68_CR17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/clinchem\/41.2.246","volume":"41","author":"SM Marcovina","year":"1995","unstructured":"Marcovina SM, Albers JJ, Gabel B et al (1995) Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurement of lipoprotein (a). Clin Chem 41:246\u2013255","journal-title":"Clin Chem"},{"key":"68_CR18","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1172\/JCI116370","volume":"91","author":"JC Cohen","year":"1993","unstructured":"Cohen JC, Chiesa G, Hobbs H (1993) Sequence polymorphisms in the apolipoprotein(a) gene. J Clin Invest 91:1630\u20131636","journal-title":"J Clin Invest"},{"key":"68_CR19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1523-1755.2004.00737.x","volume":"66","author":"F Kronenberg","year":"2004","unstructured":"Kronenberg F, Lingenhel A, Lhotta K et al (2004) Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: impact on lipid-lowering therapy. Kidney Int 66:348\u2013354","journal-title":"Kidney Int"},{"key":"68_CR20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0022-2275(20)42828-7","volume":"31","author":"JW Gaubatz","year":"1990","unstructured":"Gaubatz JW, Ghanem KI, Guevara J et al (1990) Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 31:603\u2013613","journal-title":"J Lipid Res"},{"key":"68_CR21","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0022-2275(20)37461-7","volume":"37","author":"SM Marcovina","year":"1996","unstructured":"Marcovina SM, Albers JJ, Wijsman E et al (1996) Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 37:2569\u20132585","journal-title":"J Lipid Res"},{"key":"68_CR22","unstructured":"AMA Manual of Style Committee (2007) American Medical Association manual of style: a guide for authors and editors. Section 4: Measurement and quantification,10th edn. Oxford University Press, Oxford"},{"key":"68_CR23","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","volume":"368","author":"P Libby","year":"2013","unstructured":"Libby P (2013) Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 368:2004\u20132013","journal-title":"N Engl J Med"},{"key":"68_CR24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1532-429X-14-80","volume":"14","author":"JM Grimm","year":"2012","unstructured":"Grimm JM, Nikolaou K, Schindler A et al (2012) Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by in vivo high-resolution CMR. J Cardiovasc Magn Res 14:80","journal-title":"J Cardiovasc Magn Res"}],"container-title":["Clinical Research in Cardiology Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-015-0068-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11789-015-0068-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-015-0068-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T04:27:00Z","timestamp":1651120020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11789-015-0068-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":24,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s11789-015-0068-y","relation":{},"ISSN":["1861-0706","1861-0714"],"issn-type":[{"value":"1861-0706","type":"print"},{"value":"1861-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}